News | April 20, 2015

Contego Medical Closes $5.6 Million in Series B Funding for Embolic Protection Devices

Company will use funding to continue to expand products on Integrated Embolic Protection platform

April 20, 2015 — Contego Medical announced the completion of a $5.6 million Series B financing round for the development of transcatheter angioplasty devices that integrate filter-based embolic protectionThe funding was led by Hatteras Venture Partners. Hatteras is an early stage venture firm with a focus on medical devices, biopharmaceuticals, diagnostics and related opportunities in human medicine. The round also included Mountain Group Partners, Lookout Capital and Medical Mutual.

Based in Raleigh, North Carolina, Contego Medical is developing a portfolio of novel medical devices in the cardiovascular and peripheral vascular space. The company’s portfolio of devices integrates filter-based embolic protection with treatment on the same platform, known as the Integrated Embolic Protection filter platform for angioplasty balloon and stent delivery catheters.

"Contego Medical's portfolio of angioplasty balloons and stents embodying the Integrated Embolic Protection filter platform represents a breakthrough technology, which we believe will help endovascular interventionalists reduce the risk of stroke and other procedural complications," said Doug Reed M.D., general partner of Hatteras Venture Partners. Reed will be joining Contego Medical as a board member.

The company will use the funds to continue to grow its leadership, sales and engineering teams and to develop several new and innovative products with the next-generation Integrated Embolic Protection platform.

Contego Medical has expanded its executive team with the appointment of Paul Sanders as chief operating officer, Udayan Patel as chief technology officer and Alan Bacharach as Contego Medical's European general manager. Elizabeth Saylors will continue as vice president of quality and clinical affairs.

For more information: www.contegomedical.com

Related Content

The Boston Scientific FilterWire EZ embolic protec filter system.

The Boston Scientific FilterWire EZ embolic protection system.

News | Embolic Protection Devices | October 31, 2017
October 31, 2017 — The VAMPIRE 3 study evaluated if the selective use of distal filter protection might decrease the
Claret Medical Closes $14.5 Million in Series C Financing for Sentinel Cerebral Protection System
News | Embolic Protection Devices | October 23, 2017
October 23, 2017 — Claret Medical announced that it has closed on a Series C financing of $14.5 million led by Lights
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices | September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Protembis Announces Successful First-in-Human Use of  ProtEmbo Cerebral Protection System in European Trial
News | Embolic Protection Devices | September 07, 2017
Protembis GmbH announced the first clinical applications of its ProtEmbo Cerebral Protection System to complement a...
PinnacleHealth First in Pennsylvania to Implant Sentinel Cerebral Protection System
News | Embolic Protection Devices | August 23, 2017
PinnacleHealth is the first hospital in Pennsylvania and one of the first 10 in the country to introduce new technology...
PinnacleHealth Initiates Clinical Study of TriGuard Embolic Protection Device
News | Embolic Protection Devices | April 11, 2017
Through a new clinical trial, patients at Harrisburg, Pa.-based PinnacleHealth have access to an investigational device...
Cardiogard embolic protection system for surgical valve reaplacement

The CardioGard embolic protection system for surgical aortic valve replacement.

Feature | Embolic Protection Devices | March 22, 2017
March 22, 2017 — Two U.S.
Keystone Heart, TriGuard Embolic Protection Device, real-world results, PCR London Valves Conference 2016
News | Embolic Protection Devices | September 29, 2016
Keystone Heart Ltd. recently announced the safety and efficacy of the TriGuard Cerebral Embolic Protection device...
Claret Medical, Sentinal CPS, cerebral protection system, FDA marketing application, TAVR, embolic protection
News | Embolic Protection Devices | September 20, 2016
Claret Medical announced its filing of a marketing application with the U.S. Food and Drug Administration (FDA) for...
InspireMD, CGuard, PARADIGM study, EuroPCR 2015, Musialek

Image courtesy of InspireMD

News | Embolic Protection Devices | June 23, 2015
InspireMD Inc. announced that its CGuard embolic prevention system reported positive results in the PARADIGM study at...
Overlay Init